rs886041335
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000070.3(CAPN3):c.2185-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000070.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN3 | NM_000070.3 | c.2185-2A>G | splice_acceptor_variant, intron_variant | ENST00000397163.8 | NP_000061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.2185-2A>G | splice_acceptor_variant, intron_variant | 1 | NM_000070.3 | ENSP00000380349.3 | ||||
CAPN3 | ENST00000673886.1 | c.190-2A>G | splice_acceptor_variant, intron_variant | ENSP00000501155.1 | ||||||
CAPN3 | ENST00000673928.1 | c.190-2A>G | splice_acceptor_variant, intron_variant | ENSP00000501099.1 | ||||||
CAPN3 | ENST00000674146.1 | c.190-2A>G | splice_acceptor_variant, intron_variant | ENSP00000501175.1 | ||||||
CAPN3 | ENST00000674149.1 | c.190-2A>G | splice_acceptor_variant, intron_variant | ENSP00000501112.1 | ||||||
CAPN3 | ENST00000673743.1 | c.88-2A>G | splice_acceptor_variant, intron_variant | ENSP00000500989.1 | ||||||
ENSG00000258461 | ENST00000495723.1 | n.*2621-2A>G | splice_acceptor_variant, intron_variant | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461682Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727174
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74338
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 17, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 29, 2018 | The c.2185-2 A>G splice site variant in the CAPN3 gene has been previously reported in association with limb-girdle muscular dystrophy (Richard et al., 1999; CAPN3 LOVD). This pathogenic variant destroys the canonical splice acceptor site in intron 20, and is expected to cause abnormal gene splicing. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, c.2185-2 A>G is considered a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 30, 2016 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2A Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2023 | This sequence change affects an acceptor splice site in intron 20 of the CAPN3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with clinical features of autosomal recessive limb-girdle muscular dystrophy (PMID: 10330340, 31069529; Invitae). ClinVar contains an entry for this variant (Variation ID: 280039). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 08, 2018 | - - |
Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
Pathogenic, flagged submission | clinical testing | Baylor Genetics | Jul 06, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at